Government, industry, academic studies and classifications |
| government/industry list/academic study |
appears on list as |
classification(s) |
| European Union - Classification & Labelling | MERCURY | Repr. Cat. 2; R61 T+; R26 T; R48/23 N; R50-53 |
| U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | MERCURY COMPOUNDS | Restricted in the US |
| Canada - Prohibited and Restricted Cosmetics Ingredients | MERCURY | Restricted |
| CHE Toxicant and Disease Database | MERCURY | Acute tubular necrosis - Strong |
| CHE Toxicant and Disease Database | MERCURY | ALS (Lou Gehrig's disease) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Altered sex ratio - Good |
| CHE Toxicant and Disease Database | MERCURY | Anemia (including hemolytic) - Good |
| CHE Toxicant and Disease Database | MERCURY | Aplastic anemia - Good |
| CHE Toxicant and Disease Database | MERCURY | Autoimmune antibodies (positive ANA, anti-DNA, RF, etc.) - Good |
| CHE Toxicant and Disease Database | MERCURY | Behavioral problems* - Strong |
| CHE Toxicant and Disease Database | MERCURY | Brain cancer (adult)* - Limited |
| CHE Toxicant and Disease Database | MERCURY | Bronchitis - acute - Strong |
| CHE Toxicant and Disease Database | MERCURY | Cerebral palsy - Strong |
| CHE Toxicant and Disease Database | MERCURY | Chronic renal disease - Good |
| CHE Toxicant and Disease Database | MERCURY | Cognitive impairment (includes impaired learning, impaired memory, and decreased attention span)/Mental Retardation/Developmental Delay - Strong |
| CHE Toxicant and Disease Database | MERCURY | Congenital malformations - general - Good |
| CHE Toxicant and Disease Database | MERCURY | Contact dermatitis - Irritant - Strong |
| CHE Toxicant and Disease Database | MERCURY | Coronary artery disease, peripheral vascular disease, atherosclerosis - Good |
| CHE Toxicant and Disease Database | MERCURY | Cranio- Facial malformations* - Good |
| CHE Toxicant and Disease Database | MERCURY | Decreased Coordination/ Dysequilibrium* - Strong |
| CHE Toxicant and Disease Database | MERCURY | Decreased vision (includes blindness, retinopathy, optic neuropathy) - Good |
| CHE Toxicant and Disease Database | MERCURY | Delayed growth - Good |
| CHE Toxicant and Disease Database | MERCURY | Erectile dysfunction - Limited |
| CHE Toxicant and Disease Database | MERCURY | Fetotoxicity (Miscarriage/spontaneous abortion, stillbirth) - Good |
| CHE Toxicant and Disease Database | MERCURY | Glomerulonephritis - Good |
| CHE Toxicant and Disease Database | MERCURY | Hearing loss - Strong |
| CHE Toxicant and Disease Database | MERCURY | Hormonal changes (levels of circulating sex hormones - FSH/LH, Inhibin, and/or estrogens, progesterones, androgens) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Hypertension (High blood pressure) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Immune suppression * - Good |
| CHE Toxicant and Disease Database | MERCURY | Low birth weight/Small for Gestational Age/Intra-Uterine Growth Retardation - Good |
| CHE Toxicant and Disease Database | MERCURY | Menstrual disorders (abnormal bleeding, short cycles, long cycles, irregular cycles, painful periods) - Good |
| CHE Toxicant and Disease Database | MERCURY | Minamata disease - Strong |
| CHE Toxicant and Disease Database | MERCURY | Myocardial infarction (Heart attack) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Nephrotic syndrome - Limited |
| CHE Toxicant and Disease Database | MERCURY | Neural tube defects/CNS malformations* - Good |
| CHE Toxicant and Disease Database | MERCURY | Neurosthenia (Organic affective syndrome) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Peripheral neuropathy - Strong |
| CHE Toxicant and Disease Database | MERCURY | Pneumonia - Good |
| CHE Toxicant and Disease Database | MERCURY | Pneumonitis (hypersensitivity) - Strong |
| CHE Toxicant and Disease Database | MERCURY | Psychiatric disturbances (disorientation, hallucinations, psychosis, delirium, paranoias, anxiety/depression, emotional laibility, mood changes, euphoria). - Strong |
| CHE Toxicant and Disease Database | MERCURY | Pulmonary edema - Good |
| CHE Toxicant and Disease Database | MERCURY | Pulmonary fibrosis - Limited |
| CHE Toxicant and Disease Database | MERCURY | Reduced Fertility - Female (infertility and subfertility) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Reduced Fertility - Male (infertility and subfertility) - Limited |
| CHE Toxicant and Disease Database | MERCURY | Scleroderma - Limited |
| CHE Toxicant and Disease Database | MERCURY | Seizures - Strong |
| CHE Toxicant and Disease Database | MERCURY | Spasticity/Myoclonus - Strong |
| CHE Toxicant and Disease Database | MERCURY | Thyroid disorders - Hypothyroidism - Limited |
| EPA Clean Water Act - Priority Pollutants | MERCURY | Priority Pollutants (Clean Water Act) |
| Illinois EPA Chemicals Associated with Endocrine System | MERCURY | EPA: Probable Endocrine Disruptor |
| EPA Integrated Risk Information System (IRIS) | MERCURY, ELEMENTAL | D Not classifiable as to human carcinogenicity (1986) |
| European Union - Banned or Restricted in Cosmetics | MERCURY AND ITS COMPOUNDS | Banned in EU Cosmetics (manufacturing or structural exception that allows the substance) |
| European Union - Water Framework Directive | MERCURY AND ITS COMPOUNDS | List of priority substances in the field of water policy |
| EPA Hazardous Air Pollutants | MERCURY COMPOUNDS | Hazardous Air Pollutant |
| National Library of Medicine HazMap | MERCURY | SD: Yes;SS: Yes;RT: Yes;RS: Paint manufacturers agreed to discontinued the use of mercury in exterior paints after September 1991 and in interior paints after Aug 20, 1990. [ATSDR Case Studies # 17, p. 3];TP: Yes;NE: Yes;NT: Sensorimotor Neuropathy;LC: 11 |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | MERCURY AND INORGANIC MERCURY COMPOUNDS | IARC GROUP 3 |
| Chemicals known to be neurotoxic to humans | MERCURY | known to be neurotoxic to humans |
| Our Stolen Future Endocrine Disruptors | MERCURY | Reproductive/ Thyroid |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | MERCURY COMPOUNDS | Meets or exceeds criteria for toxicity and persistent under Canadian Accelerated Reduction/Elimination of Toxics list |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | MERCURY COMPOUNDS | Tier 1 chemical of concern under the Great Lakes Binational Strategy |
| EPA PBTs - Waste Minimization Program (RCRA) | MERCURY | Priority chemical under EPA's Resource Conservation and Recovery Act (RCRA) Waste Minimization Program (WMP) |
| EPA Toxic Release Inventory PBTs | TOTALMERCURY | Very persistent, very bioaccumulative, toxic under the EPA's Toxics Release Inventory |
| EPA Toxic Release Inventory PBTs | MERCURY COMPOUNDS | Very persistent, very bioaccumulative, toxic under the EPA's Toxics Release Inventory |
| US EPA, 9204 | MERCURY | Reproductive Toxicity Hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1990 | MERCURY | Respiratory Toxicity Hazards: suspected |
| Illinois EPA, 1997 | MERCURY | Endocrine Toxicity Hazards: suspected |
| Klaassen, C, 1996 | MERCURY | Cardiovascular or Blood Toxicity Hazards: suspected |
| National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances, 1995 | MERCURY | Gastrointestinal or Liver Toxicity Hazards: suspected |
| Malachowsky, M, 1995 | MERCURY COMPOUNDS | Cardiovascular or Blood Toxicity Hazards: suspected |
| Proposition 65 List of Carcinogens | MERCURY COMPOUNDS | Cancer Hazards: suspected |
| Japan's Standards for Cosmetics | MERCURY AND ITS COMPOUNDS | Japan - prohibited for use in cosmetics |
| California EPA Proposition 65 | MERCURY AND MERCURY COMPOUNDS | developmental |
| European Commission on Endocrine Disruption | MERCURY | HH-CAT3;WF-CAT3 |
| Environment Canada Domestic Substance List | MERCURY | Y-Categorization,,,Y-Persistent,,Y-AquaticTox,,,, |
references |
| government/industry list/academic study
| reference
|
| European Union - Classification & Labelling | CPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex VI of Directive 67/548/EEC through the 31st ATP. |
| U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | FDA (U.S. Food and Drug Administration), 2006. Ingredients Prohibited and Restricted by FDA Regulations. FDA Center for Food Safety and Applied Nutrition, Office of Cosmetics and Colors. Downloaded from http://www.cfsan.fda.gov/~dms/cos-210.html. |
| Canada - Prohibited and Restricted Cosmetics Ingredients | Health Canada. 2007. List of Prohibited and Restricted Cosmetic Ingredients. Canada's Cosmetic Ingredient Hotlist. March 2007. |
| CHE Toxicant and Disease Database | CHE (The Collaborative on Health and the Environment). 2006. Toxicant and Disease Database. |
| EPA Clean Water Act - Priority Pollutants | |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. |
| EPA Integrated Risk Information System (IRIS) | EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines. |
| European Union - Banned or Restricted in Cosmetics | EC (European Commission of the European Union). 1999-2006. Enterprise Directorate-General Pharmaceuticals and Cosmetics. The rules governing cosmetic products in the European Union, Volume 1, "Cosmetics legislation." |
| European Union - Water Framework Directive | EU (European Union). 2000. Water Framework Directive (Directive 2000/60/EC ) - integrated river basin management for Europe. List of priority substances. |
| EPA Hazardous Air Pollutants | EPA (U.S. Environmental Protection Agency). 2005. Office of Air. The 112(b)1 Hazardous Air Pollutants List (as modified). Last modified: 12 Dec 2005. |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| Chemicals known to be neurotoxic to humans | Grandjean P and PJ Landrigan. 2006. Developmental neurotoxicity of industrial chemicals. Lancet. 2006 Dec 16;368(9553):2167-78. |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | EC (Environment Canada). 1994. Accelerated Reduction/Elimination of Toxics (ARET). ARET substance list of persistent, bioaccumulative and toxic chemicals. |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | Great Lakes BTS (Binational Toxics Strategy). 1997. Canada-United States Strategy for the Virtual Elimination of Persistent Toxic Substances in the Great Lakes. Appendix I - Level 1 and Level 2 substances. |
| EPA PBTs - Waste Minimization Program (RCRA) | EPA (U.S. Environmental Protection Agency). 1998. Resource Conservatin and Recovery Act (RCRA) Waste Minimization Program - priority chemicals for elimination or reduction. |
| EPA Toxic Release Inventory PBTs | EPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule. |
| Scorecard.org Toxicity Information | US EPA. Roadmaps to Sources of Information on Chemicals Listed in the Emergency Planning Community and Community Right-to-Know Act (Also Known as SARA Title 3), Section 313 Toxic Release Inventory (for Microcomputers). (Report Number EPADFDK92040). 1991. Data file distributed in 2 diskettes by Office of Pollution, Prevention, and Toxics, Environmental Protection Agency, Washington, DC. NOTE: Datasource no longer being maintained by EPA; not currently available online., Frazier , L. and M. L. Hage (eds.). Reproductive Hazards of the Workplace, Wiley Europe, 1998. Table 10 (Partial List of Reproductive Toxicants) available at http://www.pharmacy.ohio-state.edu/homepage/safety/chemhygiene_table_repro.pdf., A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, California EPA, Office of Environmental Health Hazard Assessment. Acute Reference Exposure Levels (RELs), Averaging Times, and Toxicologic Endpoints. Includes all Acute Reference Exposure Levels (ARELs) developed by OEHHA through May 2000http://www.oehha.org/air/acute_rels/allAcRELs.html |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | Illinois EPA. Endocrine Disruptors Strategy. 1997. (Table 1: Preliminary List of Chemicals Associated with Endocrine System Effects in Animals and Humans or In Vitro). http://www.nihs.go.jp/hse/environ/illiepatable.htm, Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996. |
| Scorecard.org Toxicity Information | National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| Japan's Standards for Cosmetics | Japan Ministry of Health, Labour and Welfare. 2006. Standards for Cosmetics. Evaluation and Licensing Division. Pharmaceutical and Food Safety Bureau. |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. |
| European Commission on Endocrine Disruption | EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. |
| Environment Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. |
| RTECS®- TLV/BEI,2006 [shown for informational purposes only] | RTECS®- TLV/BEI,2006 |
| RTECS®- TLV/BEI,2007 [shown for informational purposes only] | RTECS®- TLV/BEI,2007 |
| RTECS®- Toxicologist 2003 [shown for informational purposes only] | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72(Supp 1),360,2003 |
| RTECS®- Toxicologist 2003 [shown for informational purposes only] | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- 72(Supp 1),360,2003 |
| RTECS®- Zeitschrift fuer Krebsforschung 1957 [shown for informational purposes only] | RTECS®- Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. 61,511,1957 |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.
